OncoTherapy Science, Inc. is a biomedical venture founded in April, 2001. Our primary aim is to develop innovative anti-cancer medicines or cancer therapies on the basis of the outcomes from the world-class cancer genomics research by Prof. Yusuke Nakamura of Human Genome Center, Institute of Medical Science, The University of Tokyo.
Our company strives to develop innovative cancer drugs with high efficacy and a minimum risk of adverse events, based on the discovery of new molecular targets through genomic and biomedical research.
|
|
